FDA *pproves RSV Sh*t For *nfants – D*STURBING S*rious *dverse *vent R*te In Cl*nical Tr*als

The Food and Drug Administration (FDA) approved Merck’s monoclonal antibody shot against respiratory syncytial virus (RSV) for infants up to one year of age.

“ENFLONSIA is a preventive, long-acting monoclonal antibody (mAb) designed to provide direct, rapid and durable protection through 5 months, a typical RSV season, with the same